The effects of recombinant human erythropoietin on growth and nutritional status

Abstract

The availability of recombinant human erythropoietin (rhuEPO) has dramatically improved the care of children with chronic renal failure (CRF). Its use provides the opportunity to determine the relative contribution of anemia to the morbidity of CRF. Growth retardation, one of the most significant complications of CRF in children, is the consequence of… (More)
DOI: 10.1007/BF00866771

Topics

4 Figures and Tables